Introduction
skeletal deformities, joint stiffness, severe retinal Mucopolysaccharidoses (MPS) are a group of 10 disdegeneration and hearing impairment are coupled with orders caused by the deficiency of lysosomal enzymes an incremental deterioration of the neurological system. (four glycosidases, five sulfatases and one non-hydrolytic Death generally occurs between the ages of 10 and 14 transferase) needed for the catabolism of glycosaminoglyyears. cans (GAG): dermatan-, heparan-, keratan-and chondroNo mental impairment is characteristic of the mild itin-sulfate (mucopolysaccharides). Their accumulation in form, however, skeletal deformities can be present to the lysosomes results in cell, tissue or organ dysfunction same degree as in the severe form. Retinal and hearing determining various chronic and progressive patterns of problems are milder than in the severe form and the clinical severity, even within each enzyme deficiency. 1 patient can survive until the fifth or sixth decade. Usually All MPS, except Hunter syndrome, are inherited as cardiac failure or airway obstruction are the cause of autosomal recessive disorders. Hunter syndrome, MPS death. Only symptomatic treatments are available for type II, is a rare X-linked inborn error of metabolism MPS in general. Transient improvement of patient concharacterized by the deficiency of iduronate-2-sulfatase ditions have been obtained with leukocyte and plasma (IDS) (E.C. 3.1.6.13), which removes the sulfate group in infusions, 6, 7 while fibroblast and amnion transplantations dermatan-and heparan-sulfate. The defect is due to point have not been successful in restoring, even partially, any mutations or deletions in the 24 kb gene, mapping on enzyme activity or improving the objective signs. [8] [9] [10] Xq28.2. 2 The cDNA was cloned as a 2.3 kb sequence, 3, 4 Bone marrow transplantation (BMT) has been sugand successfully used to produce a recombinant active gested as a potential method for enzyme supplement for enzyme in CHO cells. 5 MPS patients, 11, 12 since enzyme replacement therapy is Hunter syndrome occurs in a severe and a mild form.
not available yet. In the case of MPSII, however, the value The severe form is characterized by progressive somatic of BMT still has to be investigated. and neurological involvements. The onset of the disease Correction by gene therapy might represent another usually occurs between the second and fourth year of route to be pursued. Hunter lymphoblastoid cell lines. 16 A phase I clinical trial affected by the mild form of the disease was also approved.
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In order to improve considerably the life condition of patients affected by the severe form of Hunter syndrome, local production of the enzyme lacking in the brain might be required. In fact, the capability of IDS enzyme to cross the blood-brain barrier still needs to be ascertained.
Since adenoviral vectors have been shown to be adequate and safe delivery systems to transfer normal sequences also to nonproliferative cells, 18-21 we generated a replication-defective adenovirus vector, derived from human adenovirus type 5, expressing the human IDS (AdRSVIDS).
Infection experiments performed on primary Hunter cells showed that AdRSVIDS was able to normalize the intralysosomal GAG accumulation; furthermore, the recombinant enzyme secreted in the extracellular compartment was endocytosed by deficient cells via the mannose-6-phosphate receptor (M6P).
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Because of the lack of animal models to perform long- 
Results
was obtained on non-reverse transcribed total RNA (Figure 2 ).
Construction of pXCRSVIDSpA
The 578 bp Rous sarcoma virus long terminal repeat IDS enzyme activity in normal and transduced (RSV-LTR) sequence was isolated from pRSVLuc 25 by fibroblasts NdeI-XbaI restriction, treated with Klenow polymerase To show that AdRSVIDS was able to express a functional and cloned as blunt end fragment into the filled in XbaI recombinant enzyme, IDS activity was tested on noninsite of pXCJL1. 26 The new plasmid was called pXCRSV. fected and infected Hunter cells compared with normal The SV40 polyA sequence containing the small intron was isolated as an 876 bp HindIII-BamHI fragment from the pSV23p construct, 27 filled in and cloned into pXCRSV after treatment with Klenow of the unique ClaI site. This plasmid was called pXCRSVpA.
The 1814 bp IDS cDNA was isolated from the construct pLX-IDS (DS Anson and JJ Hopwood, unpublished) by ClaI-SalI restriction and filled in. The cDNA was cloned into the filled in SalI site of pXCRSVpA. The final plasmid, named pXCRSVIDSpA (Figure 1 ), was used to generate the viral vector AdRSVIDS.
Molecular analysis of infected Hunter cells
The efficiency of adenovirus infection on Hunter cells was first assessed by using AdHCMVsp1lacZ vector at 100 p.f.u. per cell. Nearly 100% of cells were found to express ␤-galactosidase 24 h after infection (data not shown).
To assess the transduced IDS activity in the short and prolonged period, primary Hunter fibroblasts were subsequently infected with the vector AdRSVIDS and analysed 48 h and 30 days after infection, respectively. AdRSVIDS. Figure 3 shows that, as expected, a three-fold To evaluate IDS secretion from Hunter-infected cells, IDS activity was determined in IDS-conditioned medium a IDS activity was determined 48 h after infection.
detecting 33 ± 8 U/ml. Such levels were 10-fold higher b
Fibroblasts were included in collagen matrices and IDS activity than those measured in the medium collected from nordetermined 30 days after infection.
mal fibroblasts (Ͻ5 U/ml). with IDS-conditioned medium, while no enzyme activity was detected when Hunter cells were maintained in medium obtained from normal fibroblasts. Furthermore, ones ( Table 1) . No basal IDS activity (Ͻ5 U/mg) was observed in Hunter cells (H130, H423, H435 and H452), while normal cells showed standard IDS activity (81 ± 10 U/mg). In comparison, up to 20-fold higher expression was detected in infected Hunter cells (1758 ± 120 U/mg). In order to assay prolonged IDS expression, fibroblasts were included into collagen matrices and maintained for 30 days. We observed that 30 days after infection Hunter cells were still able to express up to 20-fold higher levels of enzyme (2580 ± 85 U/mg) with respect to normal fibroblasts (110 ± 10 U/mg) ( Table 1 ). Owing to progressive decrease of cell viability, analysis beyond 30 days could not be performed (data not shown).
Expression of lysosomal enzymes in infected Hunter fibroblasts
To evaluate whether overexpression of transduced IDS might alter the level of expression of other lysosomal enzymes, activity of ␣-N-acetyl-glucosaminidase, ␤-galactosidase, ␣-l-iduronidase, N-acetylglucosamino-6-sulfatase, galacto-6-sulfatase, acetyl-CoA:␣-glucosaminide-N-acetyltransferase, were measured in Hunter fibroblasts before and after infection. Table 2 shows that the overexpression of IDS induced by AdRSVIDS does not seem to interfere with the expression and activity of endogenous lysomal enzymes. 
cells (bar 3). After infection the level of GAG is back to normal (bar 2).
To evaluate the capability of the recombinant enzyme to expression from infected cells seemed to be crucial to showed that infected cells were highly positive to X-gal staining for a few days after IDS endocytosis is blocked by competition with M6P; no infection (3 days), but totally negative within a few cell increased IDS activity was, in fact, detected in Hunter passages (10 days). Since Hunter primary fibroblasts cells cultured with IDS-conditioned medium in the were the only cells available for this study, a reproducible presence of M6P.
system, based on derma-equivalents, able to allow prolonged expression analysis was developed. It was preDiscussion viously shown that keratinocytes or fibroblasts mixed with collagen type I contract into a tissue. 23 Within the Somatic gene transfer is a promising strategy for the tissue, cells can be maintained for prolonged periods of treatment of many metabolic disorders. Essential to any time and can reach a high degree of differentiation exhibgene therapy protocol is the expression of the transferred iting a bipolar morphology. 24 Cell division is blocked at gene which has to be targeted to the major cellular sites phases G1 and G2 and the synthesis of macromolecules of pathology in sufficient amounts to correct the meta-(collagen, noncollagen proteins, glycosaminoglycans) can bolic defect.
be identified. 29 The generation of derma-equivalents is a For the severe form of Hunter syndrome the target organ is represented by CNS. Although retroviral vectors well established technique, which has also been exploited have been shown to be the safest and more reliable vecfor medical applications 30, 31 and for the construction of tors used in the ongoing clinical trials, they cannot be secreting neo-organs for gene therapy purposes. 32, 33 In used for gene transfer of differentiated neuronal cells. In this study, the use of derma-equivalents allowed us to fact, efficient retrovirus-mediated gene transfer relies detect IDS activity up to 30 days after infection. The strictly on cell replication. On the other hand, adenovirus expression was stable and comparable to the levels measvectors have been shown to be reliable tools to infect CNS ured 48 h after infection. To our knowledge, this is the cells in vitro and in vivo 18, 19, 28 and were able to maintain first time that a prolonged term expression analysis has in vivo expression up to 6 months after infection. 18, 19 been performed in vitro by using adenovirus vectors. In this article, we describe the in vitro correction of Therefore, derma-equivalents can be proposed as a Hunter cells and the overexpression of the human IDS reliable, easy, cheap system for the analysis of adenocDNA mediated by the replication defective adenovirus virus-transduced genes in the absence of a suitable vector AdRSVIDS. The vector was able to express a animal model. recombinant IDS protein that could substantially
The vector AdRSVIDS was able to correct the metabolic decrease GAG substrate accumulation. Furthermore, it alteration typical of MPSII and therefore it might be conappeared that recombinant IDS, as the normal enzyme, sidered a valuable tool for gene therapy of patients affecwas endocytosed into cells by the M6P receptor, ted by Hunter syndrome. as shown by the lack of IDS activity in Hunter cells culAlthough our final goal will be the correction of the tured with IDS-conditioned medium in the presence enzyme defect in CNS of Hunter patients, in the absence of M6P.
of an animal model, clinical studies aimed to correct the AdRSVIDS has been shown to express high levels of IDS deficiency in CNS should be preceded by experirecombinant enzyme, up to 20-fold over normal levels, ments performed in other areas severely affected by the which was maintained for at least 30 days. The overdisease (ie joints). Such experiments should allow evaluexpression of the recombinant IDS might be due to the ation of the vector safety and hopefully its immunoinsertion of a 45 bp fragment of the rat preproinsulin genicity. In this respect, the next step will be preclinical leader sequence cloned as substitution of the 5′-nonexperiments aimed at evaluating the ability of the vector coding region of IDS. This insertion was necessary since to overexpress IDS, its safety and its immunogenicity in clones generated by stable transfection of unmodified IDS areas other than CNS in healthy animals. cDNA were producing low levels of enzyme.
5 IDS over- 
DNA cloning
Amplification of IDS transcript was performed with oliCloning was performed following standard procedures. 34 gonucleotides 423a and 424a by 35 cycles at 94°C for 1 All enzymes for DNA manipulation were purchased min, 59°C for 45 s, 72°C for 1 min with a 5′ extended from Boehringer Mannheim (Mannheim, Germany). elongation time at the last cycle. Hunter cells infected with AdHCMVsp1lacZ were analyzed 24 h after infection Cell cultures for ␤-gal expression by using X-gal staining procedure.
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Hunter (H130, H423, H435 and H452) and normal primary fibroblasts were obtained from skin biopsies.
Collagen preparation Hunter cells were obtained from patients affected by the Collagen type I was obtained from rat tails as described. 23 severe form of MPSII; primary cells obtained from three Briefly, rat tails were stored in 70% EtOH until use, tenhealthy subjects were used as a control. Cells were culdons were isolated and exposed overnight to UV light. tured in minimum essential medium (MEM) supThe day after, tendons were put in 1% glacial acetic acid plemented with 10% fetal calf serum (FCS), 2 mm l-glutaat 4°C for 48 h. Collagen was centrifuged at 15 000 g for mine, Hepes 5 g/l, nonessential amino acids, penicillin 90 min at 4°C and dialyzed against 0.1% acetic acid sol-(50 U/ml) streptomycin sulfate (50 mg/ml) and Fungiution for 6 days. Collagen concentration was determined zone (ICN, Costa Mesa, CA, USA) (125 mg/ml) by measuring hydroxyproline content as described.
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(complete medium). Cultures were incubated in a humidified atmosphere at 5% CO 2 at 37°C. All reagents Reconstitution of derma-equivalents were obtained from GIBCO BRL (Gaithersburg, MD, Normal, Hunter and virus-infected cells were mixed with USA) except for FCS, obtained from Boehringer collagen type I to reconstitute derma-equivalents. As preMannheim.
viously described, 23 1.2 × 10 6 cells were plated in complete medium to which collagen and 0.1 n sodium Generation and purification of AdRSVIDS hydroxide were added and incubated in a humidified To generate AdRSVIDS, pXCRSVIDSpA and pJM17 35 atmosphere at 5% CO 2 at 37°C. Derma-equivalents were were cotransfected in 293 cells, 36 by the Ca-P coprecipidigested by adding 2 mg/ml Collagenase Type 1A tation technique. 37 Purification and titration were perfor-(Sigma, St Louis, MO, USA) from Clostridium histolyticum med by standard procedures. 26, 38 The virus genome was and incubated for 40 min at 30°C. Cells were counted, analyzed by enzymatic restriction. Correct plaques were pellets resuspended in 150 mm NaCl and stored at −80°C purified and analyzed once more. Medium from the until used. Cell viability was assayed by trypan blue second purification was collected and used to build up a dye exclusion. high titer stock in 293 cells.
Determination of IDS enzyme activity Normal, Hunter and AdRSVIDS-infected cells were Adenovirus infection of Hunter cells Hunter primary fibroblasts were infected with 100 p.f.u.
tested for IDS activity as previously described. 42 Fortyeight hours after infection, cells were trypsinized, centriper cell of either AdRSVIDS or AdHCMVSp1lacZ, 39 the latter expressing the E. coli lacZ gene.
fuged and lysed by six cycles of freezing-thawing. Lysates were dialyzed in distilled water for 16 h at 4°C before For short-term experiments using AdRSVIDS, cells were infected and analyzed 48 h later. For prolonged assaying. Protein concentration was determined according to Bradford. 43 IDS activity was assayed using the experiments, infected cells were included in derma-equivalents for 30 days, and analyzed after collagenase digesradiolabeled disaccharide substrate L-O-(␣-iduronic acid 2-sulphate)-(1-Ͼ4)-D-O-2,5-anhydrol 3 H mannitol 6-sultion as described below.
The infection and IDS transcription was determined by phate. Briefly, 15 l of substrate solution (radioactive disulfated disaccharide, 0.22 mm, 2.6 × 10 6 c.p.m./min 0.27 PCR reaction using the following virus-specific oligonucleotides: No. 340 forward: 5′ TAC GAT CGT GCC TTA m sodium acetate buffer pH 4.0/13 mm NaN 3 ) were mixed with suitable enzyme aliquots and assayed in 80 TTA GG 3′, priming within the RSV promoter; and IDS cDNA oligonucleotides No. 5 antisense: 5′ ACG TTC l final volume. Reaction was stopped after 24 h incubation at 37°C, with 1 ml 1 mm Na 2 HPO 4 , samples were AGA GCA TCT GTG GTC GAG TTG GCC 3′, priming at position 210-239 of the IDS cDNA; 3 No. 423a forward loaded on an ECTEOLA-23 column (FLUKA, Buchs, Switzerland) and the product was eluted by adding 5 ml CAT CAG CAA GCA GGT CAT T, priming at position 20-38 of the rat preproinsulin leader sequence; 5 No. 424a 70 mm sodium formiate. Scintillation liquid Pico Fluor 40 (INSTA-GEL Packard, Meriden CT, USA) was added and reverse: CCA CAG GGC AAA GCA GGT T, priming at position 560-578 of the IDS cDNA. 3 Taq polymerase was samples were counted by a scintillation counter. Enzymatic activity was expressed as U/mg of proteins. One purchased from Roche Molecular Systems (Branchburg, NJ, USA). DNA oligonucleotides were synthesized with unit of IDS activity is the amount of enzyme required to catalyse the hydrolysis of 1% 3 H substrate per hour. a Beckman SM oligosynthesizer (Beckman Instruments, Palo Alto, CA, USA); H 2 35 SO 4 was purchased from Amersham (Buckinghamshire, UK).
Determination of lysosomal enzyme activities Hunter and AdRSVIDS-infected Hunter cells were Total DNA was isolated from cells as previously described. 34 IDS cDNA was obtained by reverse tranassayed for the following lysosomal enzymes: ␣-N-acetylglucosaminidase, ␤-galactosidase, ␣-l-iduronidase, Nscription of 20 g of total RNA obtained by using RNAZol B treatment (BIOTECX, Houston, TX, USA) according acetyl-glucosamino-6-sulfatase, galacto-6-sulfatase, acetyl-CoA:␣-glucosaminide-N-acetyltransferase according to the manufacturer's protocol. Amplification of trans-to standard procedures. 44 cells. IDS activity was measured as described above. 
